A Phase I-II Intensive-Dose Ifosfamide, Carboplatin and Taxotere (IC-T) Combination Chemotherapy Followed by Autologous Stem Cell Rescue for Patients With Refractory Malignancies
Phase of Trial: Phase I/II
Latest Information Update: 10 Sep 2005
At a glance
- Drugs Docetaxel (Primary) ; Carboplatin; Ifosfamide
- Indications Advanced breast cancer; Hodgkin's disease; Non-Hodgkin's lymphoma; Ovarian cancer; Testicular cancer
- Focus Adverse reactions
- 10 Sep 2005 New trial record.